Amanote Research
Register
Sign In
T-Bet Expression in Intratumoral Lymphoid Structures After Neoadjuvant Trastuzumab Plus Docetaxel for HER2-overexpressing Breast Carcinoma Predicts Survival
British Journal of Cancer
- United Kingdom
doi 10.1038/bjc.2011.261
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 1, 2011
Authors
S Ladoire
L Arnould
G Mignot
L Apetoh
C Rébé
F Martin
P Fumoleau
B Coudert
F Ghiringhelli
Publisher
Springer Science and Business Media LLC
Related search
Effectiveness of Neoadjuvant Trastuzumab and Chemotherapy in HER2-overexpressing Breast Cancer
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Validation of Intratumoral T-Bet+ Lymphoid Cells as Predictors of Disease-Free Survival in Breast Cancer
Cancer immunology research
Cancer Research
Immunology
High HER2/Centromeric Probe for Chromosome 17 Fluorescence in Situ Hybridization Ratio Predicts Pathologic Complete Response and Survival Outcome in Patients Receiving Neoadjuvant Systemic Therapy With Trastuzumab for HER2-Overexpressing Locally Advanced Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Prolonged Survival of Patients Receiving Trastuzumab Beyond Disease Progression for HER2 Overexpressing Metastatic Breast Cancer (MBC)
Oncology Research and Treatment
Cancer Research
Oncology
Hematology
Trastuzumab Plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer
New England Journal of Medicine
Medicine
Trastuzumab-Dm1: A Review of the Novel Immuno-Conjugate for HER2- Overexpressing Breast Cancer
The Open Breast Cancer Journal
Neoadjuvant Chemotherapy With Docetaxel, Carboplatin and Weekly Trastuzumab Is Active in HER2-Positive Early Breast Cancer: Results After a Median Follow-Up of Over 4 Years
Breast Care
Surgery
Oncology
Breast Carcinoma With Amplified HER2: A Gene Expression Signature Specific for Trastuzumab Resistance and Poor Prognosis
Modern Pathology
Forensic Medicine
Pathology
Resistance to Trastuzumab in HER2-Positive Mucinous Invasive Ductal Breast Carcinoma
Clinical Breast Cancer
Cancer Research
Oncology
